These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37564954)

  • 1. Association Between Mean Platelet Volume and Benign Prostatic Hyperplasia: A Population Study from the TCLSIH Cohort Study.
    Song Y; Gu Y; Guo H; Yang H; Wang X; Wu H; Wang A; Wang M; Wang H; Zhang Q; Liu L; Meng G; Liu B; Niu K
    J Inflamm Res; 2023; 16():3259-3269. PubMed ID: 37564954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Neutrophil-to-Lymphocyte Ratio and Benign Prostatic Hyperplasia: Results from the TCLSIH Cohort Study.
    Song Y; Gu Y; Guo H; Yang H; Wang X; Wu H; Wang A; Wang H; Zhang Q; Zhang Q; Liu L; Meng G; Liu B; Niu K
    J Inflamm Res; 2023; 16():4857-4866. PubMed ID: 37904787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S; Tang J; Shao S; Yan Y
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated red blood cell distribution width in benign prostatic hyperplasia patients with metabolic syndrome.
    Dong X; Liao Y; Chen K; Fang Y; Li W; Chen J; You L; Li S
    Int J Clin Exp Med; 2015; 8(1):1213-9. PubMed ID: 25785115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
    Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
    Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.
    Chen W; Man S; Wang B; Kadeerhan G; Huang X
    Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
    Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
    Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.
    Zhao SC; Xia M; Tang JC; Yan Y
    Sci Rep; 2016 Sep; 6():33933. PubMed ID: 27653367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects.
    Zhu C; Wu J; Wu Y; Guo W; Lu J; Zhu W; Li X; Xu N; Zhang Q
    Front Nutr; 2022; 9():999995. PubMed ID: 36263299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impacts of metabolic syndrome and lifestyle on the prevalence of benign prostatic hyperplasia requiring treatment: historical cohort study of 130 454 men.
    Yoo S; Oh S; Park J; Cho SY; Cho MC; Jeong H; Son H
    BJU Int; 2019 Jan; 123(1):140-148. PubMed ID: 30125452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
    Fu Y; Zhou Z; Yang B; Zhang K; He L; Zhang X
    Urol Int; 2016; 97(3):330-335. PubMed ID: 27509202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate Prostate Cancer from Benign Prostate Hyperplasia.
    Fu S; Zhang X; Niu Y; Wang RT
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):699-702. PubMed ID: 29580043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of mean platelet volume with incident type 2 diabetes mellitus risk: the Dongfeng-Tongji cohort study.
    Li Z; Wang J; Han X; Yuan J; Guo H; Zhang X; Zheng D; Tang Y; Yang H; He M
    Diabetol Metab Syndr; 2018; 10():29. PubMed ID: 29651306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
    Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
    Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men.
    Park YW; Min SK; Lee JH
    World J Mens Health; 2012 Dec; 30(3):183-8. PubMed ID: 23596610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
    Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching.
    Xiong Y; Zhang Y; Tan J; Qin F; Yuan J
    Transl Androl Urol; 2021 Jan; 10(1):384-396. PubMed ID: 33532326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.
    Kwon H; Kang HC; Lee JH
    Urology; 2013 Jun; 81(6):1325-9. PubMed ID: 23602796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.